(PPHM:Consolidated Issue listed on NASDAQ Capital Market)
Bruce Allan Chabner M.D.
Medical and Scientific Advisor, Peregrine Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 58 board members in 4 different organizations across 9 different industries.|
See Board Relationships
Dr. Bruce Allan Chabner, M.D., is an Advisor of Thomas, McNerney & Partners and focuses on investments in Oncology. Dr. Chabner serves as Scientific Advisor of Lumicell, Inc. Dr. Chabner serves as Medical and Scientific Advisor at Peregrine Pharmaceuticals Inc. Dr. Chabner has been an Associate Director of Clinical Science at the Dana-Farber/Harvard Cancer Center since 1999, which includes the Massachusetts General Hospital, Brigham & Women's Hospital, Dana-Farber Cancer ...
14282 Franklin AvenuePhone: 714-508-6000
Tustin, California 92780
Board Members Memberships*
Director and Member of Compensation Committee
Harvard Medical School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|J. Joseph Kim Ph.D.||Chief Executive Officer, President, Director and Member of Finance Committee|
Inovio Pharmaceuticals, Inc.
|Douglas J. Swirsky CPA, CFA||Chief Executive Officer, President, Corporate Secretary and Director|
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Eddie Gray||Chief Executive Officer and Director|
Dynavax Technologies Corporation
|William D. Clark||Chief Executive Officer, President and Director|
Genocea Biosciences, Inc.
|$393.6K||Compensation as of Fiscal Year 2014.|